![](/images/Email.png)
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human SGLT2 expressed in CHO cells assessed as decrease in uptake of [14C]AMG after 120 mins by TopCount methodMore data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human SGLT2More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human SGLT2More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Inhibition of SGLT2 (unknown origin)More data for this Ligand-Target Pair
TargetSodium/glucose cotransporter 2(Homo sapiens (Human))
Haisco Pharmaceuticals Group
Curated by ChEMBL
Haisco Pharmaceuticals Group
Curated by ChEMBL
Affinity DataIC50: 1.80nMAssay Description:Inhibition of human HA-tagged SGLT2 expressed in HEK293 cells assessed as decrease in [14C]-AMG uptake measured after 1 to 2 hrs by scintillation cou...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)